Full Schedule

Speaker: Laura Rosiñol, Doctor (she/her/hers) – Hospital Clinic de Barcelona

Speaker: Yael C. Cohen, MD (she/her/hers) – Tel- Aviv Sourasky (Ichilov) Medical Center, and Faculty of health Science, Tel Aviv University, Tel Aviv, Israel

Speaker: Gordon Cook, PhD, DSc – Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK

Speaker: Ashley Rosko, MD (she/her/hers) – The Ohio State University

Speaker: Rafael Fonseca, MD – Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA

Speaker: Leo Rasche, MD – Department of Internal Medicine II, University Hospital, 97080 Würzburg, Germany

Speaker: Morie A. Gertz, MD, MACP (he/him/his) – Mayo Clinic

Speaker: Heinz Ludwig, MD (he/him/his) – Wilhelminen Cancer Research Institute, c/o Department of Medicine I, Klinik Ottakring

Co-Chair: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust

Co-Chair: Edvan q. Crusoe, MD, MDc, PhD (he/him/his) – UFBA and Rede D'or Oncologia

Speaker: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust

Speaker: Edvan q. Crusoe, MD, MDc, PhD (he/him/his) – UFBA and Rede D'or Oncologia

Speaker: Suzanne Lentzsch, MD, PhD (she/her/hers) – Columbia University

Speaker: Adam D. Cohen, MD – Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

Speaker: Meletios A. Dimopoulos, MD – National and Kapodistrian University of Athens

Panelist: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust

Panelist: Suzanne Lentzsch, MD, PhD (she/her/hers) – Columbia University

Panelist: Adam D. Cohen, MD – Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

Panelist: Meletios A. Dimopoulos, MD – National and Kapodistrian University of Athens

Speaker: Edvan q. Crusoe, MD, MDc, PhD (he/him/his) – UFBA and Rede D'or Oncologia

Speaker: Edvan q. Crusoe, MD, MDc, PhD (he/him/his) – UFBA and Rede D'or Oncologia

Speaker: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust

Co-Chair: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA

Chair: Simon J. Harrison, MBBS, MRCP(uk), FRCPath(uk), FRACP, PhD (he/him/his) – Peter MacCallum Cancer Centre

Speaker: Jill CORRE, PharmD, PhD (she/her/hers) – Institut Universitaire du Cancer de Toulouse-Oncopole

Speaker: Wee Joo Chng, MB ChB, PhD, FRCP (UK), FRCPath (UK), FAMS (he/him/his) – National University Cancer Institute, Singapore

Speaker: Martin F. Kaiser, MD, FRCP, FRCPath – The Institute of Cancer Research; Royal Marsden Hospital

Speaker: Katja Weisel, MD (she/her/hers) – University Medical Center of Hamburg-Eppendorf, Hamburg, Germany

Speaker: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA

Panelist: Angelo Maiolino – Universidade Federal do Rio de Janeiro

Panelist: Jill CORRE, PharmD, PhD (she/her/hers) – Institut Universitaire du Cancer de Toulouse-Oncopole

Panelist: Wee Joo Chng, MB ChB, PhD, FRCP (UK), FRCPath (UK), FAMS (he/him/his) – National University Cancer Institute, Singapore

Panelist: Martin F. Kaiser, MD, FRCP, FRCPath – The Institute of Cancer Research; Royal Marsden Hospital

Panelist: Katja Weisel, MD (she/her/hers) – University Medical Center of Hamburg-Eppendorf, Hamburg, Germany

Chair: Jayr Schmidt, MD (he/him/his) – A.C.Camargo Cancer Center

Speaker: Jayr Schmidt, MD (he/him/his) – A.C.Camargo Cancer Center

Speaker: Susan Bal, MD – University of Alabama at Birmingham

Speaker: Cesar Rodriguez, MD – Icahn School of Medicine at Mount Sinai

Speaker: Rahul Banerjee, MD (he/him/his) – Fred Hutchinson Cancer Center

Panelist: Jayr Schmidt, MD (he/him/his) – A.C.Camargo Cancer Center

Panelist: Susan Bal, MD – University of Alabama at Birmingham

Panelist: Cesar Rodriguez, MD – Icahn School of Medicine at Mount Sinai

Panelist: Rahul Banerjee, MD (he/him/his) – Fred Hutchinson Cancer Center

Speaker: Jayr Schmidt, MD (he/him/his) – A.C.Camargo Cancer Center

Co-Chair: Andrea D. Preston, MRPharmS (Consultant) (she/her/hers) – NHS / Sanius Health

Co-Chair: Beth Faiman, PhD, MSN, APN-BC, BMTCN, AOCN, FAAN, FAPO (she/her/hers) – Cleveland Clinic

Chair: Philippe Moreau, MD, PhD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Chair: Pieter Sonneveld, MD, PhD (he/him/his) – EMN

Speaker: Luciano J. Costa, MD, PhD – University of Alabama at Birmingham, Birmingham, AL, USA

Speaker: Paula Rodriguez-Otero, MD PhD (she/her/hers) – Clinica Universidad de Navarra

Panelist: Thomas Martin, MD – Department of Hematology, University of California at San Francisco, San Francisco, CA, USA

Panelist: Michel Delforge, MD/Phd (he/him/his) – University of Leuven, Leuven, Belgium

Co-Chair: Keith Stewart, MB ChB – Princess Margaret Cancer Centre, University Health Network

Chair: Vania Hungria, MD, PhD – Department of Hematology, Clinica São Germano, São Paulo, Brazil

Speaker: Mehmet K. Samur, PhD – Dana-Farber Cancer Institute

Speaker: P.Joy Ho, MBBS DPhil FRACP FRCPA – Institute of Haematology, Royal Prince Alfred Hospital

Speaker: Marc S. Raab, MD PhD (he/him/his) – Dept. of Medicine V Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany

Speaker: Hang Quach, MBBS(Hons) SpecCertOC FRACP FRCPA MD (she/her/hers) – St Vincent’s Hospital Melbourne, University of Melbourne, VIC, Australia

Speaker: Keith Stewart, MB ChB – Princess Margaret Cancer Centre, University Health Network

Panelist: Pankaj Malhotra, MD – Postgraduate Institute of Medical Education and Research, Chandigarh

Panelist: Mehmet K. Samur, PhD – Dana-Farber Cancer Institute

Panelist: P.Joy Ho, MBBS DPhil FRACP FRCPA – Institute of Haematology, Royal Prince Alfred Hospital

Panelist: Marc S. Raab, MD PhD (he/him/his) – Dept. of Medicine V Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany

Panelist: Hang Quach, MBBS(Hons) SpecCertOC FRACP FRCPA MD (she/her/hers) – St Vincent’s Hospital Melbourne, University of Melbourne, VIC, Australia

Co-Chair: Charlotte Pawlyn, PhD, FRCP, FRCPath (she/her/hers) – The Institute of Cancer Research

Co-Chair: Andrzej Jakubowiak

Speaker: Susan Bal, MD – University of Alabama at Birmingham

Speaker: Meletios A. Dimopoulos, MD – National and Kapodistrian University of Athens

Speaker: Nisha S. Joseph, MD – Winship Cancer Institute, Emory University

Speaker: Xavier P. Leleu, MD, PhD (he/him/his) – Hospital La Mileterie, Poitiers, France

Speaker: Paula Rodriguez-Otero, MD PhD (she/her/hers) – Clinica Universidad de Navarra